MIMS

DEVICE2 trials

Sponsors

Sanoculis Ltd

Conditions

GlaucomaThis Study is Conducted Under Inclusion/ Exclusion Criteria

Unknown Phase

Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study

CompletedNCT05638321

Sanoculis LtdThis Study is Conducted Under Inclusion/ Exclusion Criteria

Start: 2022-04-11End: 2024-03-12Updated: 2024-03-12

The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP): The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP)

CompletedNCT07051174

Sanoculis LtdGlaucoma

Start: 2022-04-11End: 2023-10-27Updated: 2025-07-04